Publication

Morenz AM, Reddy A, Hsu A, Le A, Wong ES, Liao JM. 2024. Disparities in telemedicine use among Native Hawaiian and Pacific Islander individuals insured through Medicaid. Health Affairs Scholar. 2(5).

Herbst-Kralovetz MM, Roe D, Chase D, Willmott L, Borst M, Mourad J, Cui H, Laniewski P, Lorentzen G. 2024 Apr. 30. Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification. Clinical Cancer Research. doi:https://doi.org/10.1158/1078-0432.CCR-23-2934.

Ver Hoeve ES, Calhoun E, Hernandez M, High E, Armin JS, Ali-Akbarian L, Frithsen M, Andrews W, Hamann HA. 2024. Evaluating implementation of a community-focused patient navigation intervention at an NCI-designated cancer center using RE-AIM. BMC Health Services Research. 24(1). doi:10.1186/s12913-024-10919-y.

Lee D, Huntoon K, Wang Y, Kang M, Lu Y, Jeong SD, Link TM, Gallup TD, Qie Y, Li X, et al. 2024. Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells. Nature Biomedical Engineering. 8(5):593–610.

Plank M, Carmiol N, Mitri B, Lipinski AA, Langlais PR, Capaldi AP. 2024. Systems level analysis of time and stimuli specific signaling through PKA. Kellogg D, editor. Molecular Biology of the Cell. 35(4). doi:10.1091/mbc.e23-02-0066.

Jose E, March-Steinman W, Wilson BA, Shanks L, Parkinson C, Alvarado-Cruz I, Sweasy JB, Paek AL. 2024. Temporal coordination of the transcription factor response to H2O2 stress. Nature Communications. 15(1). doi:10.1038/s41467-024-47837-w.

Fairman CM, Kava CM, Beima-Sofie K, Sakhuja M, Masud M, Dias E, Sheng J, Gorzelitz J, Morshed A, Green BB, et al. 2024 Mar. Addressing differences in cancer: a framework for synergistic programming in cancer prevention and control. doi:10.21203/rs.3.rs-4046415/v1.

Mahmud M, Munjal A, Savani M, Win H, Rozell U, Arshad J. 2024. Biomarker Testing and Role of Tyrosine Kinase Inhibitors and Immunotherapy for Esophageal Squamous Cell Carcinoma. Foregut: The Journal of the American Foregut Society. 4(4):467–474. doi:10.1177/26345161241238748.

Wang Z, Li W, Jiang Y, Park J, Gonzalez KM, Wu X, Zhang Q-Y, Lu J. 2024. Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery. Nature Communications. 15(1). doi:10.1038/s41467-024-46331-7.

Lou E, Xiu J, Baca Y, Saeed A, Prakash A, Gholami S, Subramanian S, Starr TK, Fontana E, Pandey R, et al. 2024. Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers. Molecular Therapy: Oncology. 32(1):200786.

Arshad J, Rao A, Repp ML, Rao R, Wu C, Merchant JL. 2024. Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International Journal of Molecular Sciences. 25(5):2985. doi:10.3390/ijms25052985.

Gunning JA, Gilman KE, Zúñiga TM, Simpson RJ, Limesand KH. 2024. Parotid glands have a dysregulated immune response following radiation therapy. Fujiwara K, editor. PLOS ONE. 19(3):e0297387. doi:10.1371/journal.pone.0297387.

Block Ngaybe MG, Ravi P, Rosales A, Camarena JL, Madhivanan P. 2024. Systematic review study protocol of literature from 2018 to end of 2022 of stated preference studies about HIV care and prevention services around the world. BMJ Open. 14(3):e072661. doi:10.1136/bmjopen-2023-072661.

Buller DB, Sussman AL, Thomson CA, Kepka D, Taren D, Henry KL, Warner EL, Walkosz BJ, Woodall WG, Nuss K, et al. 2024. #4Corners4Health Social Media Cancer Prevention Campaign for Emerging Adults: Protocol for a Randomized Stepped-Wedge Trial. JMIR Research Protocols. 13:e50392. doi:10.2196/50392.

Valencia CI, Wightman P, Morrill KE, Hsu C, Arif‐Tiwari H, Kauffman E, Gachupin FC, Chipollini J, Lee BR, Garcia DO, et al. 2024. Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona. Cancer Medicine. 13(3). doi:10.1002/cam4.7007.

Coffee Z, Hsu C-H, Vanderah TW, Gordon JS. 2024. Predictors of Enrollment and Adherence in a Randomized Tobacco Cessation Clinical Trial. Tobacco Use Insights. 17. doi:10.1177/1179173x241308136.

Xiao Y, Zhang X, Li Y, Shi G, Krunz M, Nguyen DN, Hoang DT. 2024. Time-Sensitive Learning for Heterogeneous Federated Edge Intelligence. IEEE Transactions on Mobile Computing. 23(2):1382–1400. doi:10.1109/tmc.2023.3237374.

Fu Z, Tseng HW, Vedantham S. 2024. An attenuation field network for dedicated cone beam breast CT with short scan and offset detector geometry. Scientific Reports. 14(1). doi:10.1038/s41598-023-51077-1.

Bradshaw CM, Georgieva T, Tankersley TN, Taylor-Doyle T, Johnson L, Uhrlaub JL, Besselsen D, Nikolich JŽ. 2024. Cutting Edge: Characterization of Low Copy Number Human Angiotensin-Converting Enzyme 2–Transgenic Mice as an Improved Model of SARS-CoV-2 Infection. The Journal of Immunology. 212(4):523–528. doi:10.4049/jimmunol.2300591.

Quaid M, Goodrich JM, Calkins MM, Graber JM, Urwin D, Gabriel J, Caban‐Martinez AJ, Petroff RL, Grant C, Beitel SC, et al. 2024. Firefighting, per‐ and polyfluoroalkyl substances, and DNA methylation of genes associated with prostate cancer risk. Environmental and Molecular Mutagenesis. 65(1–2):55–66. doi:10.1002/em.22589.

Nawrocki ST, Espitia C, Carrera Espinoza MJ, Jones TM, Gamble ME, Sureshkumar S, Chang M, Wang W, Carew JS. 2024. Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib. Clinical and Translational Medicine. 14.

Buss LG, Rheinheimer BA, Limesand KH. 2024. Radiation-induced changes in energy metabolism result in mitochondrial dysfunction in salivary glands. Scientific Reports. 14(1). doi:10.1038/s41598-023-50877-9.

Duan S, Sawyer TW, Witten BL, Song H, Else T, Merchant JL. 2024. Spatial profiling reveals tissue‐specific neuro‐immune interactions in gastroenteropancreatic neuroendocrine tumors. The Journal of Pathology. 262(3):362–376. doi:10.1002/path.6241.

Zhang W, Krunz M, Ditzler G. 2024. Stealthy Adversarial Attacks on Machine Learning-Based Classifiers of Wireless Signals. IEEE Transactions on Machine Learning in Communications and Networking. 2:261–279. doi:10.1109/tmlcn.2024.3366161.

Osipov A, Nikolic O, Gertych A, Parker S, Hendifar A, Singh P, Filippova D, Dagliyan G, Ferrone CR, Zheng L, et al. 2024. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. Nature Cancer. 5(2):299–314.